Janney Montgomery Scott LLC boosted its stake in Icon Plc (NASDAQ:ICLR) by 11.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,237 shares of the medical research company’s stock after purchasing an additional 1,222 shares during the period. Janney Montgomery Scott LLC’s holdings in Icon were worth $1,394,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in ICLR. Koch Industries Inc. increased its stake in Icon by 17,508.8% in the 2nd quarter. Koch Industries Inc. now owns 666,140 shares of the medical research company’s stock worth $659,000 after purchasing an additional 662,357 shares during the period. FMR LLC increased its stake in Icon by 38.4% in the 2nd quarter. FMR LLC now owns 2,291,005 shares of the medical research company’s stock worth $224,037,000 after purchasing an additional 635,950 shares during the period. Janus Henderson Group PLC increased its stake in Icon by 48.4% in the 2nd quarter. Janus Henderson Group PLC now owns 1,068,159 shares of the medical research company’s stock worth $104,488,000 after purchasing an additional 348,292 shares during the period. Mckinley Capital Management LLC Delaware increased its stake in Icon by 2,674.8% in the 2nd quarter. Mckinley Capital Management LLC Delaware now owns 338,520 shares of the medical research company’s stock worth $33,104,000 after purchasing an additional 326,320 shares during the period. Finally, Principal Financial Group Inc. increased its stake in Icon by 71.5% in the 3rd quarter. Principal Financial Group Inc. now owns 768,471 shares of the medical research company’s stock worth $87,513,000 after purchasing an additional 320,356 shares during the period. 89.66% of the stock is currently owned by institutional investors and hedge funds.

Icon Plc (NASDAQ:ICLR) opened at $114.55 on Thursday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.90 and a current ratio of 1.90. Icon Plc has a 12 month low of $73.93 and a 12 month high of $124.48. The stock has a market capitalization of $6,190.00, a P/E ratio of 21.59, a PEG ratio of 1.74 and a beta of 0.61.

Icon (NASDAQ:ICLR) last posted its earnings results on Thursday, October 26th. The medical research company reported $1.35 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.32 by $0.03. Icon had a return on equity of 28.42% and a net margin of 16.37%. The firm had revenue of $440.30 million for the quarter, compared to analysts’ expectations of $438.09 million. During the same period in the previous year, the firm earned $1.19 earnings per share. The business’s revenue was up 4.8% compared to the same quarter last year. sell-side analysts anticipate that Icon Plc will post 5.37 EPS for the current fiscal year.

A number of equities analysts have commented on ICLR shares. Zacks Investment Research cut Icon from a “hold” rating to a “sell” rating in a research note on Wednesday, October 4th. Credit Suisse Group reaffirmed an “outperform” rating and issued a $120.00 price target (up from $105.00) on shares of Icon in a research note on Monday, October 16th. Jefferies Group reaffirmed a “buy” rating and issued a $122.00 price target on shares of Icon in a research note on Tuesday, September 12th. Bank of America started coverage on Icon in a research note on Monday, September 11th. They issued a “buy” rating and a $128.00 price target on the stock. Finally, ValuEngine raised Icon from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Four equities research analysts have rated the stock with a hold rating, seven have given a buy rating and two have given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $121.00.

COPYRIGHT VIOLATION NOTICE: “Janney Montgomery Scott LLC Has $1.39 Million Holdings in Icon Plc (ICLR)” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/12/21/janney-montgomery-scott-llc-has-1-39-million-holdings-in-icon-plc-iclr.html.

About Icon

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.

Institutional Ownership by Quarter for Icon (NASDAQ:ICLR)

Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.